Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/38284
Title: | Early accrual of organ damage in systemic sclerosis: Rationale for development of a disease damage index. | Authors: | Walker J.;Zochling J.;Proudman S.M.;Nikpour M.;Tay T.;Huq M.;Ferdowsi N.;Stevens W.;Sahhar J. ;Ngian G.-S.;Roddy J. | Institution: | (Tay, Huq, Ferdowsi, Stevens, Nikpour) Department of Rheumatology, St. Vincent's Hospital, Fitzroy, VIC, Australia (Tay, Huq, Ferdowsi, Nikpour) Department of Medicine, University of Melbourne, Fitzroy, VIC, Australia (Sahhar, Ngian) Department of Rheumatology, Monash Health, Clayton, VIC, Australia (Sahhar) Department of Medicine, Monash University, Clayton, VIC, Australia (Roddy) Royal Perth Hospital, Perth, WA, Australia (Zochling) Menzies Institute for Medical Research, Hobart, TAS, Australia (Walker) Department of Rheumatology, Flinders Medical Centre, Bedford Park, SA, Australia (Proudman) Rheumatology Unit, Royal Adelaide Hospital, North Terrace, Adelaide, Australia (Proudman) Discipline of Medicine, University of Adelaide, Adelaide, Australia | Issue Date: | 11-Jul-2018 | Copyright year: | 2017 | Publisher: | SAGE Publications Ltd (E-mail: info@sagepub.co.uk) | Place of publication: | Italy | Publication information: | Journal of Scleroderma and Related Disorders. 2 (2) (pp 127-134), 2017. Date of Publication: 2017. | Abstract: | Introduction: Systemic sclerosis (SSc) is characterized by irreversible organ damage rather than fluctuating disease activity. However, there is no validated measure of damage in SSc. We aimed to quantify the accrual of organ damage in patients with early SSc. Method(s): Patients enrolled in the Australian Scleroderma Cohort Study with less than 2 years of SSc since the onset of the first non-Raynaud's symptom were included. Organ damage was defined by a group of six experts as substantial and permanent loss of organ function due to SSc. Result(s): We identified 278 patients with early SSc. Among these, 38% had diffuse SSc. Damage was more common in the diffuse than in the limited disease subtype in the skin/musculoskeletal (75% vs. 25. 2%, p<0.001) and lung (31.4% vs. 19. 9%, p = 0.035) domains at year seven. The rates of damage accrual were highest in the skin/musculoskeletal, gastrointestinal and respiratory systems at year two (29.1%, 18.7%, 14.4%), increasing at year five (41.4%, 30.6%, 21.2%) and declining thereafter to year seven (43.9%, 32.7%, 23.0%). In particular, there was early accrual of damage due to joint contracture (22.3%), gastrointestinal dysmotility (11.5%) and pulmonary fibrosis with forced vital capacity <70% predicted (9.7%) at year two. The highest accrual rate of organ-specific damage from years two to seven was seen in fecal incontinence followed by proximal muscle weakness and pulmonary fibrosis. Conclusion(s): Substantial accrual of organ damage occurs early in the course of disease, particularly in diffuse SSc. This provides the rationale for the development of a SSc damage index.Copyright © 2017 Wichtig International. | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.5301/jsrd.5000239 | ISSN: | 2397-1983 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/38284 | Type: | Article | Type of Clinical Study or Trial: | Observational study (cohort, case-control, cross sectional or survey) |
Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.